NSUN5 and prostate carcinoma: Conversely, phosphorylated NSUN5 catalyzes m5C modification of ACC1 mRNA, which binds to ALYREF to enhance its stability and nuclear output, promoting ACC1 expression and lipid deposition in prostate cancer cells [71].